Loading clinical trials...
Loading clinical trials...
Ibrutinib (a tyrosine kinase inhibitor targeting Bruton) is a standard of treatment in haematology. According to retrospective data, atrial fibrillation and systemic hypertension are common ibrutinib-...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
European Georges Pompidou Hospital
NCT06263491 · Mantle Cell Lymphoma
NCT06252675 · Mantle Cell Lymphoma
NCT05529069 · Mantle Cell Lymphoma, Non Hodgkin Lymphoma, and more
NCT05006716 · B-cell Malignancy, Marginal Zone Lymphoma, and more
NCT06026319 · Non-hodgkin Lymphoma, Relapsed Non-Hodgkin Lymphoma, and more
Assistance Publique Hôpitaux de Paris - Centre Université de Paris
Paris
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions